How Specialty Pharmacy Can Address and Impact Social Determinants of Healthhttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper discusses how Shields care model and patient management system help overcome common barriers to addressing SDOH by allowing for the use of data insights to screen patients…
Advancements in Rare Disease Treatment and Managementhttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper discusses how health system-owned specialty pharmacies leveraging Shields’ integrated care model, data aggregation and acceleration solutions can overcome challenges and barriers to care for specialty patients with…
Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturershttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper discusses how a specialty pharmacy acceleration company allows drug manufacturers to access the expertise of health systems and their specialty pharmacies through a single point of contact.…
Addressing Total Cost of Care Across the Specialty Populationhttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper describes the impact of health system specialty pharmacy utilizing an integrated care model on clinical outcomes and total cost of care.
How Specialty Pharmacy Can Drive Better Outcomes in Diabeteshttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper explores the benefits of applying a high-touch specialty pharmacy care model, such as the Shields Diabetes Care Program, in reducing HbA1c levels and providing other clinical and…
How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosishttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper explores how a high-touch integrated specialty pharmacy care model can help patients with cystic fibrosis manage the complexity of their treatment regimen and achieve their therapy goals.…
How Specialty Pharmacy Can Drive Better Outcomes in Multiple Sclerosishttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper explores how a high-touch IDN (Integrated Delivery Network) specialty pharmacy model can help MS patients overcome barriers to medication access and achievement of therapy goals, including limited…
More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patientshttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
Drug manufacturers, payers and high-performing health system specialty pharmacies can leverage the size, scope and scale of a partner like Excelera to create efficiencies and improve the care of complex patients. Among the topics in this white paper:
Continuing Trends, Unexpected Changes: Optimizing Specialty Pharmacy in a New Environmenthttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper describes the growth of health system specialty pharmacy in recent years, acknowledges the disruption caused by COVID-19, and discusses opportunities to optimize specialty pharmacy with data-driven solutions,…
How health system specialty pharmacies will help payers succeed in a value-based, data-driven futurehttps://www.shieldshealthsolutions.com/wp-content/uploads/2021/06/shields-blog-icon-case-whitepaper.svg204115Shields Health SolutionsShields Health Solutions//www.shieldshealthsolutions.com/wp-content/uploads/2021/05/shields-logo-white.svg
This white paper highlights the importance of collaboration between payers and health systems and the benefits of carving in specialty pharmacy access at the point of care. These partnerships are…